Advances in Cancer Biology-Metastasis' 2026 Journal Metrics Score is 2.5, ranking Q2 in Oncology. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 3.53.
Not available — there are not enough recent PubMed records with both received and accepted dates.
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
18 of 123 works · same type, year & subfield
1 works · same type, year & subfield
Below field-year expectation
of 1,112 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.47, so its typical recent paper runs about 53% below its field benchmark.
14.6% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2021–2025
123 OpenAlex works · 2021–2024
OpenAlex topics show the research communities this journal serves.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Cancer Research | Q3 |
| Oncology | Q2 |
A solid Q2 journal by citation data
By citation data, Advances in Cancer Biology-Metastasis is a solid journal: it is Q2 in Oncology, the second quarter of journals by score, and ranks #368 of 897 Oncology journals by Journal Metrics Score (top 42%). Advances in Cancer Biology-Metastasis' 2026 Journal Metrics Score is 2.5. OpenAlex lists an indicative article processing charge of $2,650 USD. OpenAlex classifies its papers in subfields including Cancer Research and Oncology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Advances in Cancer Biology-Metastasis' papers in subfields including Cancer Research and Oncology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Advances in Cancer Biology-Metastasis homepage ↗Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.
OpenAlex lists an indicative article processing charge of $2,650 USD for this open-access journal. Check the current fee, waivers, and any institutional agreement on the journal website.
Advances in Cancer Biology-Metastasis does not publish an acceptance rate.
Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversBy citation data, Advances in Cancer Biology-Metastasis is a solid journal: it is Q2 in Oncology, the second quarter of journals by score, and ranks #368 of 897 Oncology journals by Journal Metrics Score (top 42%). Advances in Cancer Biology-Metastasis' 2026 Journal Metrics Score is 2.5. OpenAlex lists an indicative article processing charge of $2,650 USD. OpenAlex classifies its papers in subfields including Cancer Research and Oncology, so check that your topic fits its scope.
Advances in Cancer Biology-Metastasis' 2026 Journal Metrics Score is 2.5, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Advances in Cancer Biology-Metastasis or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Advances in Cancer Biology-Metastasis' quartile and score with similar journals, or ask the editorial office.
Advances in Cancer Biology-Metastasis' best quartile is Q2. By OpenAlex subfield: Q3 in Cancer Research; Q2 in Oncology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Advances in Cancer Biology-Metastasis will not match this score exactly. Compare journals using one source at a time.
OpenAlex lists an indicative article processing charge of $2,650 USD for Advances in Cancer Biology-Metastasis. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include Journal of Experimental & Clinical Cancer Research, Biochimica Et Biophysica Acta-Reviews On Cancer, Cancer Science, and Cellular Oncology. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.